Table 1.
Symptoms, care, test, and treatment for COVID-19 infection in ALL patients (N = 675).
| Characteristics | N | Percentage (%) |
|---|---|---|
| Symptoms | ||
| No symptoms | 40 | 5.9 |
| Fever | 532 | 78.8 |
| Cough | 386 | 57.2 |
| Fatigue | 199 | 29.5 |
| Sore throat | 178 | 26.4 |
| Headache | 124 | 18.4 |
| Myalgia | 119 | 17.6 |
| Dizziness | 100 | 14.8 |
| Chills | 90 | 13.3 |
| Vomit | 68 | 10.1 |
| Nausea | 65 | 9.6 |
| Ageusia | 64 | 9.6 |
| Diarrhea | 60 | 8.9 |
| Anosmia | 39 | 5.8 |
| Chest pain | 11 | 1.6 |
| Dyspnea | 9 | 1.3 |
| Treatment | ||
| No treatment | 140 | 20.7 |
| Antipyretics | 482 | 71.4 |
| Paxlovid | 7 | 1.0 |
| Granulocyte colony-stimulating factor | 32 | 4.7 |
| Antibiotics | 84 | 12.4 |
| Oral | 40 | 5.9 |
| Intravenous | 44 | 6.5 |
| Intravenous immunoglobulin | 19 | 2.8 |
| Corticosteroids | 5 | 0.7 |
| Oxygen support | 11 | 1.6 |
| Ventilator support | 4 | 0.6 |
| Place of care | ||
| Hospital admission from community | 35 | 6.8 |
| Pediatric ICU treatment required | 5 | 0.7 |
| Laboratory tests* | ||
| Lymphocytes count | ||
| <0.3 × 109/L | 32 | 5.3 |
| ≥0.3 × 109/L | 570 | 94.7 |
| Neutrophil count | ||
| <0.5 × 109/L | 77 | 11.8 |
| ≥0.5 × 109/L | 578 | 88.2 |
| Radiological imaging* | ||
| Pneumonia changes | 39 | 5.8 |
ALL: Acute lymphoblastic leukemia; COVID-19: Coronavirus disease 2019; ICU: Intensive care unit. *Data are not available in all patients.